Andrew Germain

599 total citations
14 papers, 431 citations indexed

About

Andrew Germain is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Andrew Germain has authored 14 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Andrew Germain's work include Trypanosoma species research and implications (4 papers), Cancer Cells and Metastasis (3 papers) and Cyclopropane Reaction Mechanisms (3 papers). Andrew Germain is often cited by papers focused on Trypanosoma species research and implications (4 papers), Cancer Cells and Metastasis (3 papers) and Cyclopropane Reaction Mechanisms (3 papers). Andrew Germain collaborates with scholars based in United States and Switzerland. Andrew Germain's co-authors include Jianglong Zhu, John A. Porco, Jianglong Zhu, John A. Porco, Michelle Palmer, José R. Perez, Benito Muñoz, Leigh Carmody, Partha P. Nag and Stuart L. Schreiber and has published in prestigious journals such as Angewandte Chemie International Edition, The Journal of Organic Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Andrew Germain

14 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Germain United States	10	273	126	71	43	34	14	431
C. O'Dowd United Kingdom	10	171 0.6×	333 2.6×	115 1.6×	28 0.7×	22 0.6×	15	436
Stephen M. Lynch United States	15	391 1.4×	110 0.9×	53 0.7×	48 1.1×	14 0.4×	29	563
Fu‐Ming Kuo Taiwan	6	406 1.5×	135 1.1×	56 0.8×	82 1.9×	9 0.3×	8	489
Xiao‐Hui Gu China	9	311 1.1×	223 1.8×	128 1.8×	33 0.8×	11 0.3×	13	606
Hirotada Takahashi Japan	8	177 0.6×	189 1.5×	26 0.4×	99 2.3×	17 0.5×	8	477
Niefang Yu China	9	206 0.8×	142 1.1×	31 0.4×	46 1.1×	18 0.5×	13	346
Peter K. Park United States	11	277 1.0×	291 2.3×	26 0.4×	30 0.7×	29 0.9×	11	517
Tai Wei Ly Taiwan	13	178 0.7×	139 1.1×	32 0.5×	49 1.1×	14 0.4×	26	435
Steve Fidanze United States	12	300 1.1×	171 1.4×	61 0.9×	101 2.3×	10 0.3×	13	497
Rammohan R. Yadav India	12	353 1.3×	145 1.2×	23 0.3×	56 1.3×	13 0.4×	13	475

Countries citing papers authored by Andrew Germain

Since Specialization

Citations

This map shows the geographic impact of Andrew Germain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Germain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Germain more than expected).

Fields of papers citing papers by Andrew Germain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Germain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Germain. The network helps show where Andrew Germain may publish in the future.

Co-authorship network of co-authors of Andrew Germain

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Germain. A scholar is included among the top collaborators of Andrew Germain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Germain. Andrew Germain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Dockendorff, Chris, Patrick W. Faloon, Andrew Germain, et al.. (2015). Discovery of bisamide-heterocycles as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake. Bioorganic & Medicinal Chemistry Letters. 25(12). 2594–2598. 9 indexed citations

2.

Germain, Andrew, Leigh Carmody, Partha P. Nag, et al.. (2013). Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells. Bioorganic & Medicinal Chemistry Letters. 23(6). 1834–1838. 14 indexed citations

3.

Dandapani, Sivaraman, Andrew Germain, Jean‐Charles Marié, et al.. (2013). Diversity-Oriented Synthesis Yields a New Drug Lead for Treatment of Chagas Disease. ACS Medicinal Chemistry Letters. 5(2). 149–153. 35 indexed citations

4.

Carmody, Leigh, Andrew Germain, Juan C. Engel, et al.. (2013). Identification of Diversity-Oriented Synthesis Derived Small Molecule, ML341, with Cidal Activity Against Trypanosoma cruzi. 2 indexed citations

5.

Germain, Andrew, Leigh Carmody, Barbara J. Morgan, et al.. (2012). Identification of a selective small molecule inhibitor of breast cancer stem cells. Bioorganic & Medicinal Chemistry Letters. 22(10). 3571–3574. 31 indexed citations

6.

Carmody, Leigh, Andrew Germain, Lynn VerPlank, et al.. (2012). Phenotypic High-Throughput Screening Elucidates Target Pathway in Breast Cancer Stem Cell–Like Cells. SLAS DISCOVERY. 17(9). 1204–1210. 28 indexed citations

7.

Dockendorff, Chris, M. Marek Nagiec, Michel Weïwer, et al.. (2012). Macrocyclic Hedgehog Pathway Inhibitors: Optimization of Cellular Activity and Mode of Action Studies. ACS Medicinal Chemistry Letters. 3(10). 808–813. 30 indexed citations

8.

Germain, Andrew, Leigh Carmody, Chris Dockendorff, et al.. (2011). Identification of small-molecule inhibitors of Trypansoma cruzi replication. Bioorganic & Medicinal Chemistry Letters. 21(23). 7197–7200. 13 indexed citations

9.

Carmody, Leigh, Andrew Germain, Esther Bettiol, et al.. (2011). Identification of Small-Molecule Inhibitors of Trypansoma cruzi Infection - Probe 1. Europe PMC (PubMed Central). 1 indexed citations

10.

Bittker, Joshua A., Michel Weïwer, Wei Guo, et al.. (2011). Discovery of Inhibitors of Anti-Apoptotic Protein A1. 5 indexed citations

11.

Germain, Andrew, et al.. (2011). Synthesis of the Azaphilones (+)-Sclerotiorin and (+)-8-O-Methylsclerotiorinamine Utilizing (+)-Sparteine Surrogates in Copper-Mediated Oxidative Dearomatization. The Journal of Organic Chemistry. 76(8). 2577–2584. 48 indexed citations

12.

Ross, Nathan T., Hanh Le, Catherine M. Cahill, et al.. (2011). Identification of a small molecule that selectively inhibits alpha-synuclein translational expression. Europe PMC (PubMed Central). 7 indexed citations

13.

Zhu, Jianglong, Andrew Germain, & John A. Porco. (2004). Synthesis of Azaphilones and Related Molecules by Employing Cycloisomerization of o‐Alkynylbenzaldehydes. Angewandte Chemie. 116(10). 1259–1263. 54 indexed citations

14.

Zhu, Jianglong, Andrew Germain, & John A. Porco. (2004). Synthesis of Azaphilones and Related Molecules by Employing Cycloisomerization of o‐Alkynylbenzaldehydes. Angewandte Chemie International Edition. 43(10). 1239–1243. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact